NEW YORK (GenomeWeb News) – ProQinase and Crelux have agreed to a partnership to develop and market crystal-grade protein kinases to pharmaceutical and biotechnology customers, the German companies said today.
 
Under the agreement, ProQinase will produce and exclusively market recombinant protein kinases that are optimized for crystallization, and Crelux will perform quality control for each crystal grade protein batch. Crelux also will continue to provide crystallization and x-ray crystallography services, the firms said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.